Correlation of low CD73 expression on synovial lymphocytes with reduced adenosine generation and higher disease severity in juvenile idiopathic arthritis

Arthritis and Rheumatology

Volumn 67, Issue 2, 2015, Pages 545-554

  Gordon Smith, Sophie Botta ^a   Ursu, Simona ^a   Eaton, Simon ^a   Moncrieffe, Halima ^b   Wedderburn, Lucy R ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; ADENOSINE KINASE; B CELL MATURATION ANTIGEN; CD19 ANTIGEN; CD8 ANTIGEN; ECTO 5' NUCLEOTIDASE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 6; METHOTREXATE; PERFORIN; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; 5' NUCLEOTIDASE; ADENOSINE; BIOLOGICAL MARKER; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; NT5E PROTEIN, HUMAN; NUCLEOTIDASE;

ARTHRITIS; ARTICLE; B LYMPHOCYTE ACTIVATION; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL CULTURE; CELL DIVISION; CELL INFILTRATION; CELL LEVEL; CELL PROLIFERATION; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME RELEASE; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; INFLAMMATION; JUVENILE RHEUMATOID ARTHRITIS; LYMPHOCYTE; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SYNOVIAL FLUID LEVEL; SYNOVIAL FLUID MONONUCLEAR CELL; SYNOVIOCYTE; T LYMPHOCYTE ACTIVATION; TREATMENT RESPONSE; ADOLESCENT; ARTHRITIS, JUVENILE; B LYMPHOCYTE; CASE CONTROL STUDY; FEMALE; MALE; METABOLISM; PATHOLOGY; PHENOTYPE; SEVERITY OF ILLNESS INDEX; SYNOVIAL FLUID; T LYMPHOCYTE;

5'-NUCLEOTIDASE; ADENOSINE; ADOLESCENT; ANTIGENS, CD8; ARTHRITIS, JUVENILE; B-LYMPHOCYTES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELL PROLIFERATION; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; FEMALE; GPI-LINKED PROTEINS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; NUCLEOTIDASES; PHENOTYPE; SEVERITY OF ILLNESS INDEX; SYNOVIAL FLUID; T-LYMPHOCYTES;

EID: 84922795849     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38959     Document Type: Article

References (27)

1. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31: 390-2.
2. Murray KJ, Luyrink L, Grom AA, Passo MH, Emery H, Witte D, et al. Immunohistological characteristics of T cell infiltrates in different forms of childhood onset chronic arthritis. J Rheumatol 1996; 23: 2116-24.
3. Bodin P, Burnstock G,. Increased release of ATP from endothelial cells during acute inflammation. Inflamm Res 1998; 47: 351-4.
4. Schenk U, Westendorf AM, Radaelli E, Casati A, Ferro M, Fumagalli M, et al. Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels. Sci Signal 2008; 1: 6.
5. De Jager W, Hoppenreijs EP, Wulffraat NM, Wedderburn L, Kuis W, Prakken BJ,. Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. Ann Rheum Dis 2007; 66: 589-98.
6. Huang S, Apasov S, Koshiba M, Sitkovsky M,. Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 1997; 90: 1600-10.
7. Romio M, Reinbeck B, Bongardt S, Hüls S, Burghoff S, Schrader J,. Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells. Am J Physiol Cell Physiol 2011; 301: C530-9.
8. Moncrieffe H, Nistala K, Kamhieh Y, Evans J, Eddaoudi, Eaton S, et al. High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population. J Immunol 2010; 185: 134-43.
9. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A,. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997; 40: 1202-9.
10. Nistala K, Adams S, Cambrook H, Ursu S, Olivito B, de Jager W, et al. Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc Natl Acad Sci U S A 2010; 107: 14751-6.
11. Pesenacker AM, Bending D, Ursu S, Wu Q, Nistala K, Wedderburn L,. CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines. Blood 2013; 121: 2647-58.
12. Dong RP, Kameoka J, Hegen M, Tanaka T, Xu Y, Schlossman SF, et al. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. J Immunol 1996; 156: 1349-55.
13. Thompson SD, Murray KJ, Grom AA, Passo MH, Choi E, Glass DN,. Comparative sequence analysis of the human T cell receptor beta chain in juvenile rheumatoid arthritis and juvenile spondylarthropathies: evidence for antigenic selection of T cells in the synovium. Arthritis Rheum 1998; 41: 482-97.
14. Cho BA, Sim JH, Park JA, Kim HW, Yoo WH, Lee SH, et al. Characterization of effector memory CD8+ T cells in the synovial fluid of rheumatoid arthritis. J Clin Immunol 2012; 32: 709-20.
15. Deaglio S, Dwyer K, Gao W, Friedman D, Usheva A, Erat A, et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007; 204: 1257-65.
16. Montesinos M, Takedachi M, Thompson L, Wilder TF, Fernandez P, Cronstein B,. The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5′-nucleotidase: findings in a study of ecto-5′-nucleotidase gene-deficient mice. Arthritis Rheum 2007; 56: 1440-5.
17. Flogel U, Burghoff S, van Lent PL, Temme S, Galbarz L, Ding Z, et al. Selective activation of adenosine A2A receptors on immune cells by a CD73-dependent prodrug suppresses joint inflammation in experimental rheumatoid arthritis. Sci Transl Med 2012; 4: 108.
18. Rittiner JE, Korboukh I, Hull-Ryde EA, Jin J, Janzen WP, Frye SV, et al. AMP is an adenosine A1 receptor agonist. J Biol Chem 2012; 287: 5301-9.
19. Hansen KR, Resta R, Webb CF, Thompson L,. Isolation and characterization of the promoter of the human 5′-nucleotidase (CD73)-encoding gene. Gene 1995; 167: 307-12.
20. Narravula S, Lennon PF, Mueller BU, Colgan SP,. Regulation of endothelial CD73 by adenosine: paracrine pathway for enhanced endothelial barrier function. J Immunol 2000; 165: 5262-8.
21. Pharoah DS, Varsani H, Tatham RW, Newton KR, de Jager W, Prakken B, et al. Expression of the inflammatory chemokines CCL5, CCL3 and CXCL10 in juvenile idiopathic arthritis, and demonstration of CCL5 production by an atypical subset of CD8+ T cells. Arthritis Res Ther 2006; 8: R50.
22. Kobie JJ, Shah PR, Yang L, Rebhahn JA, Fowell DJ, Mosmann TR,. T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′-adenosine monophosphate to adenosine. J Immunol 2006; 177: 6780-6.
23. Corcione A, Ferlito F, Gattorno M, Gregorio A, Pistorio A, Gastaldi R, et al. Phenotypic and functional characterization of switch memory B cells from patients with oligoarticular juvenile idiopathic arthritis. Arthritis Res Ther 2009; 11: R150.
24. Schena F, Volpi S, Faliti CE, Penco F, Santi S, Proietti M, et al. Dependence of immunoglobulin class switch recombination in B cells on vesicular release of ATP and CD73 ectonucleotidase activity. Cell Rep 2013; 3: 1824-31.
25. Thompson L, Ruedi JM, O'Connor RD, Bastian JF,. Ecto-5′-nucleotidase expression during human B cell development: an explanation for the heterogeneity in B lymphocyte ecto-5′-nucleotidase activity in patients with hypogammaglobulinemia. J Immunol 1986; 137: 2496-500.
26. Dawicki DD, Agarwal KC, Parks RE,. Adenosine metabolism in human whole blood: effects of nucleoside transport inhibitors and phosphate concentration. Biochem Pharmacol 1988; 37: 621-6.
27. Chan ES, Cronstein B,. Methotrexate: how does it really work? Nat Rev Rheumatol 2010; 6: 175-8.